We are Committed to Providing the Best Care for Cancer Patients

The National Center for Cancer Care and Research (NCCCR) is the premier and only cancer hospital in the State of Qatar. It is part of Hamad Medical Corporation (HMC) and looks after cancer patients who require ongoing treatments such as chemotherapy, targeted hormone immunotherapy and radiotherapy. NCCCR also treats benign and malignant hematology disorders and provides Bone Marrow Transplants in addition to palliative care and pain management clinic. Surgical oncology services are delivered in its partner hospital, Hamad general hospital.

NCCCR provides a warm, welcoming and healing environment focused on delivering high-quality and safe patient care while adopting cutting-edge technology and the latest methodologies for providing world-class cancer therapies. This includes an inpatient admitting department, outpatient clinic, chemo day care, short-stay inpatient admission, and urgent care facility and consultation services.

We lunch genetic counselling and testing service in 2013, which is part of the Hereditary and High-Risk Screening Clinic at NCCCR, which provides a comprehensive genetic risk assessment for patients who are concerned about their hereditary cancer risk because of a personal and/or family history.

We also have unique supportive clinics such as a pain management clinic, cardio-oncology clinic

The National Cancer Strategy for Qatar, which was launched in 2011, stipulates a number of recommendations for improving the cancer journey for patients and these recommendations translate to direct improvements in patient care at NCCCR.

At NCCCR, our patients are at the heart of every decision and innovation. The hospital houses the first PET CT scanner in the region, which is a highly advanced way for cancers to be detected and monitored to improve patient outcomes.

In addition, there is urgent care section at the hospital for patients with symptomatic cancers who need to be on an urgent base operating 24 hours.

NCCCR has received accreditation from Joint Commission International (JCI) again since 2011.

JCI accreditation is based on quality and safety across all clinical and management functions.

In addition, NCCCR has been chosen as one of three hospitals in the Middle East to pilot a new hand hygiene initiative by JCI based on their attention to quality and patient safety.
and has the highest standards to keep our environment safe for the immune-compromised patient

The radiation therapy department has the highest technology for cancer treatment which is guided by medical imaging such as CT, MRI and PET/CT, which aims to destroy cancer cells while sparing healthy tissues using external or internal radiation therapy. The devices available in our department for delivering the radiation are:

  • Ethos™ LINAC: The first system in GCC, which is an artificial intelligence-powered system designed to deliver fully adaptive radiation therapy treatment within a 15-minute timeslot
  • Cyberknife®: It is an advanced form of cancer therapy and the first and only fully robotic radiotherapy device.
  • Two LINACs: Devices most commonly used for external beam radiation treatments for patients with cancer. It delivers high-energy x-rays or electrons to the region of the patient's tumor.
  • MRgFUS HIFU: High-intensity focused ultrasound (HIFU) is a Magnetic resonance-guided treatment non-invasive therapeutic technique that uses non-ionizing ultrasonic waves to heat or ablate tissue.
  • HDR Brachytherapy: It is internal radiotherapy which involves inserting thin tubes and/or needles with a radiation source into the area to be treated.

 Education programs are a strong focus for staff at NCCCR, and efforts in these areas are translated into improvements in patient care. This supports HMC in its role as an academic healthcare provider and a world-leading center of excellence in clinical care, medical education

Our fellowship training program for medical oncology got ACGME-I accreditation in 2016 for clinical haematology in 2021. Accreditation Council for Graduate Medical Education International (ACGME-I) is an independent, not-for-profit, physician-led organization that sets and monitors the professional educational standards essential in preparing physicians to deliver safe, high-quality medical care.

A well-developed national cancer registry database supports our research, Cap accredited laboratory services, fully equipped state-of-the-art radiology department. We conduct several types of research ranging from epidemiological, translation, and clinical trial